During the past decade, Northern Jiangsu People's Hospital conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 8 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 4 clinical trials were completed. i.e. 5.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Jiangsu People's Hospital" #1 sponsor was "Yangzhou University" with 20 trials, followed by "Jiangsu HengRui Medicine Co., Ltd." with 8 trials sponsored, "Zhuan Zhang" with 6 trials sponsored, "BeiGene" with 4 trials sponsored and "Subei People's Hospital of Jiangsu Province" with 4 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Jiangsu People's Hospital" #1 collaborator was "Fujian Medical University Union Hospital" with 3 trials as a collaborator, "Northern Jiangsu Province People's Hospital" with 3 trials as a collaborator, "Subei People's Hospital of Jiangsu Province" with 3 trials as a collaborator, "Beijing Hospital" with 2 trials as a collaborator and "China-Japan Union Hospital, Jilin University" with 2 trials as a collaborator. Other collaborators include 123 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "Northern Jiangsu People's Hospital" are "Chronic Heart Failure" (5 trials), "Atrial Fibrillation" (3 trials), "Colorectal Cancer" (3 trials), "Dexmedetomidine" (3 trials) and "Helicobacter Pylori Infection" (3 trials). Many other conditions were trialed in "Northern Jiangsu People's Hospital" in a lesser frequency.

Most popular intervention types in "Northern Jiangsu People's Hospital" are "Drug" (92 trials), "Other" (9 trials), "Device" (8 trials), "Procedure" (8 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Cisplatin" (5 trials), "Tislelizumab" (5 trials), "normal saline" (4 trials) and "Amoxicillin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northern Jiangsu People's Hospital" are 111 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 55 active trials in "Northern Jiangsu People's Hospital". 1 are not yet recruiting, 41 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Northern Jiangsu People's Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Jiangsu People's Hospital, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 36 trials that are defined as “Not Applicable".